advertisement

---

McMenemy MG 2

Showing records 1 to 2 | Display all abstracts from McMenemy MG

52519 Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
Whitson JT; Realini T; Nguyen QH; McMenemy MG; Goode SM
Clinical Ophthalmology 2013; 7: 1053-1060

---

52857 Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%
Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
Journal of Ocular Pharmacology and Therapeutics 2013; 29: 290-297

---